End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 CNY | -4.95% | -22.77% | -48.82% |
Apr. 03 | Chinese Securities Regulator Warns Zhongke Biotechnology Over Late Disclosure of Unit's Suspension | MT |
Apr. 02 | China stocks roughly flat as sentiment remains subdued; HK shares up | RE |
Sales 2021 | 192M 26.55M | Sales 2022 | 681M 94.01M | Capitalization | 4.63B 639M |
---|---|---|---|---|---|
Net income 2021 | -23M -3.17M | Net income 2022 | -141M -19.46M | EV / Sales 2021 | 55.1 x |
Net Debt 2021 | 1.4B 193M | Net Debt 2022 | 1.38B 190M | EV / Sales 2022 | 8.82 x |
P/E ratio 2021 |
-395
x | P/E ratio 2022 |
-32.7
x | Employees | 908 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 61.58% |
1 day | -4.95% | ||
1 week | -22.77% | ||
Current month | -56.31% | ||
1 month | -42.52% | ||
3 months | -37.55% | ||
6 months | -47.89% | ||
Current year | -48.82% |
Managers | Title | Age | Since |
---|---|---|---|
Rui Chen
CEO | Chief Executive Officer | 51 | 16-08-01 |
Chun Xiang Dong
DFI | Director of Finance/CFO | 37 | 21-07-26 |
Bao Lin Zhang
IRC | Investor Relations Contact | 32 | 20-10-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cun Zai Han
CHM | Chairman | 59 | 07-07-25 |
Bao Qing Shen Tu
BRD | Director/Board Member | 58 | 23-01-29 |
Rui Chen
CEO | Chief Executive Officer | 51 | 16-08-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.73 | -4.95% | 2,159,400 |
24-04-22 | 1.82 | -5.21% | 261,200 |
24-04-19 | 1.92 | -4.95% | 601,100 |
24-04-18 | 2.02 | -5.16% | 353,500 |
24-04-17 | 2.13 | -4.91% | 397,100 |
End-of-day quote Shanghai S.E., April 22, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.82% | 164M | |
+6.55% | 107B | |
-4.43% | 63.84B | |
+10.00% | 36.62B | |
+39.05% | 39.13B | |
+5.75% | 32.72B | |
+6.72% | 19.19B | |
+11.92% | 16.69B | |
+15.49% | 14.78B | |
+5.60% | 14.73B |
- Stock Market
- Equities
- 600165 Stock